- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Top 3 therapeutic areas by spending in the U.S. 2012-2016
Top 3 therapeutic areas by spending in the U.S. 2012-2016
Top 3 therapeutic areas by spending in the U.S. from 2012 to 2016 (in billion U.S. dollars)
This statistic shows the leading three therapy areas in the United States from 2012 to 2016, based on spending. In 2016, some 45.5 billion U.S. dollars were spent in the area of oncologics, which ranked this therapeutic area first.
Top 3 therapeutic areas by spending in the U.S. from 2012 to 2016 (in billion U.S. dollars)
Loading statistic...
| Therapeutic area | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Antidiabetics | 22.3 | 25.6 | 33.7 | 43.9 | 51.5 |
| Oncologics | 25.6 | 28.1 | 33.1 | 39.1 | 45.5 |
| Autoimmune | 15.2 | 18.3 | 23.5 | 30.2 | 37.2 |
| Therapeutic area | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Antidiabetics | 22.3 | 25.6 | 33.7 | 43.9 | 51.5 |
| Oncologics | 25.6 | 28.1 | 33.1 | 39.1 | 45.5 |
| Autoimmune | 15.2 | 18.3 | 23.5 | 30.2 | 37.2 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the leading three therapy areas in the United States from 2012 to 2016, based on spending. In 2016, some 45.5 billion U.S. dollars were spent in the area of oncologics, which ranked this therapeutic area first.
Show more- Show sources information
- Show publisher information
- Release date
- May 2017
- Region
- United States
- Survey time period
- 2012 to 2016
- Supplementary notes
- Therapy areas are based on proprietary QuintilesIMS definitions. Includes prescription and insulin products sold into chain and independent pharmacies, food store pharmacies, mail service pharmacies, long-term care facilities, hospitals, clinics, and other institutional settings. Excludes OTC.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- May 2017
More information
- Region
- United States
- Survey time period
- 2012 to 2016
- Supplementary notes
- Therapy areas are based on proprietary QuintilesIMS definitions. Includes prescription and insulin products sold into chain and independent pharmacies, food store pharmacies, mail service pharmacies, long-term care facilities, hospitals, clinics, and other institutional settings. Excludes OTC.
- Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Cancer
- 95 page/s
- English
- pptx
- Detailed references
Everything On "Cancer" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Cancer"
- Overview - Worldwide
The most important statistics
- Number of deaths caused by selected chronic diseases worldwide as of 2016 (in 1,000)Deaths caused by chronic diseases 2016
- Number of cancer deaths worldwide in 2016, by major type of cancerCancer deaths worldwide by major type 2016
- Prevalence of diagnosed cancer conditions in selected countries as of 2018Adult population diagnosed with cancer by country 2018
- Distribution of diagnosed cancer in selected countries as of 2018, by genderAdult population diagnosed with cancer in select countries by gender 2018
- Lifestyle among patients with cancer in selected countries as of 2018*Cancer sufferers based on lifestyle habits by select country 2018
- Availability of new cancer drugs launched in 2012-2016 in selected countries as of 2017Availability of new cancer drugs by country as of 2017
- Percentage of global oncology spending in 2010, 2015, and 2017, by region*Share of oncology market spending worldwide by region 2010 vs 2017
- Overview - United States
The most important statistics
- Distribution of the 10 leading causes of death in the United States in 2017Leading causes of death in the United States 2017
- Percentage of U.S. population who has (or ever had) cancer between 2000 and 2016, by age Percentage of population with cancer in the U.S. 2000-2016
- Estimated number of new cancer cases and deaths in the U.S. for 2019, by gender*Number of new cancer cases and deaths in the U.S. by gender 2019
- Probability of developing invasive cancer in the U.S. for the period 2013-2015, by gender and ageU.S. likelihood of developing invasive cancer 2013-2015 by gender and age
- Incidence rates
The most important statistics
- Incidence rates for cancer in the United States for the period 2011-2015, by gender (per 100,000 population)United States: incidence rates for cancer 2011-2015, by gender
- Incidence rate of cancer in the U.S. for the period 2011-2015, by ethnic group and gender (per 100,000 population)Cancer: incidence rate in the U.S. by ethnic group and gender 2011-2015
- Estimated number of new cancer cases among men in the U.S. in 2009 and 2019, by cancer type*U.S. number of cancer cases among men in 2009 and 2019
- Estimated number of new cancer cases among women in the U.S. in 2009 and 2019, by cancer type*U.S. number of cancer cases among women 2009 and 2019
- U.S. states with the highest cancer incidence rates in 2014 (per 100,000 population)*U.S. states with highest cancer incidence rates 2014
- U.S. states with the lowest cancer incidence rates in 2014 (per 100,000 population)*U.S. states with lowest cancer incidence rates 2014
- Death rates
The most important statistics
- Deaths by cancer in the U.S. from 1950 to 2016 (per 100,000 population)*Deaths by cancer in the U.S. 1950-2016
- Cancer death rates in the United States for the period 2012-2016, by type and gender (per 100,000 population)U.S. death rates from cancer by type and gender 2012-2016
- Cancer death rates in the U.S. for the period 2012-2016, by ethnic group and gender (per 100,000 population)U.S. mortality rates from cancer by ethnic group and gender 2012-2016
- Estimated number of cancer deaths among men in the U.S. in 2009 and 2019, by cancer typeU.S. number of cancer deaths among men 2009 and 2019
- Estimated number of cancer deaths among women in the U.S. in 2009 and 2019, by cancer typeU.S. number of cancer deaths among women 2009 and 2019
- Deaths by prostate cancer in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by prostate cancer in the U.S. 1950-2016
- Deaths by breast cancer in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by breast cancer in the U.S. 1950-2016
- U.S. states with the highest cancer death rates in 2016 (per 100,000 population)*U.S. states with highest cancer death rates 2016
- Probability of surviving
The most important statistics
- Five-year relative cancer survival rates in the U.S. for the period 2008-2014, by type of cancerCancer: 5-year survival rates in the U.S. 2008-2014
- Five-year relative cancer survival rates in the U.S. in periods between 1975 and 2014, by ethnic group Cancer: 5-year survival rates in the U.S. by ethnic group 1975-2014
- Number of U.S. Americans with a history of cancer living between 2004 and 2016 (in millions)U.S. Americans with a history of cancer living 2004-2016
- Risk factors
The most important statistics
- Percentage of U.S. adults who believed the following increased a person's risk of getting cancer as of 2018Leading beliefs about cancer risk factors among U.S. adults as of 2018
- Percentage of U.S. adults with cancer that had select lifestyle habits as of 2018, by ageLifestyle habits of U.S. cancer patients 2018, by age
- Proportion of cancer deaths attributable to cigarette smoking among adults 30 years and older in the U.S. in 2014, by cancer typeShare of cancer deaths due to smoking among U.S. adults 2014, by type
- Rate of overweight and obesity-related invasive cancer cases in the United States in 2014, by cancer type (per 100,000 population)Rate of overweight and obesity-related cancer cases U.S. 2014, by cancer type
- Relative risk for select colorectal cancer risk factors in the U.S. as of 2017*Relative risk for colorectal cancer risk factors in the U.S. as of 2017
- Percentage of U.S. adults who did the following to reduce their risk of getting cancer as of 2018Ways in which U.S. adults reduced their risk of cancer as of 2018
- Cancer drug market
The most important statistics
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2016
- Top 3 therapeutic areas by spending in the U.S. from 2012 to 2016 (in billion U.S. dollars)Top 3 therapeutic areas by spending in the U.S. 2012-2016
- Top 10 pharmaceutical companies based on global oncology revenue in 2017 and 2024 (in million U.S. dollars)Global oncology revenue by top ten pharmaceutical companies 2017 and 2024
- Top 5 oncology products worldwide based on revenue in 2017 and 2024 (in million U.S. dollars)*Top 5 worldwide oncology products by revenue 2017 and 2024
- Leading U.S. oncology brands based on revenue in 2016 (in million U.S. dollars)Top U.S. oncology products by revenue in 2016
- Number of cancer drugs in development in the United States in select years between 2005 and 2018Number of cancer drugs in development in the U.S. 2005-2018
Popular Related Keywords
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on biosimilars by type 2014
- U.S. spending on specialty medicine by type 2012-2016
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- New medicine availability by therapy area worldwide 2013
- Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Global medicine spending share by disease forecast 2020
- Top therapy areas in the U.S. by number of prescriptions 2016
- Payment method for prescriptions dispensed in the U.S. 2012-2016
- NDA/BLA filing to FDA approval times for new drugs in select disease areas 2006-2015
- Citalopram out of pocket price in the U.S. 2004-2016
- U.S. drug development Phase I to approval success rates 2006-2015 by disease area
- Pharmaceutical industry - top therapeutic classes by sales
- U.S. NDA/BLA filing approval for new drugs in select disease areas 2006-2015
- Prescription spending per capita for U.S. under 26-agers by insurance 2010-2020
- Domestic sales value of medical chemical products in Taiwan 2008-2017
- Northern Ireland: share of individuals taking prescribed medicine for a year, by age
- Antibacterials for systemic use: consumption in Netherlands 2016
- Medicine LPI in Japan 2008-2017
- Total prescription spending in the U.S. 2010-2020
Studies
- Personalized medicine
- Prescribed Drug Spending in Canada, 2018
- Patented Medicine Prices Review Board - Annual Report 2017
- Meds Entry Watch 2017
- Patented Medicine Prices Review Board - Annual Report 2016
- Prescribed Drug Spending in Canada, 2017
- Drug Use Among Seniors in Canada, 2016
- Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2...
- Meds Entry Watch 2016
- Compass Rx - Annual Public Drug Plan Expenditure Report 2015/16
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015
- Prescribing for Diabetes, England 2007/08 to 2017/18
- Patented Medicine Prices Review Board - Annual Report 2013
- Patented Medicine Prices Review Board - Annual Report 2014
- Patented Medicine Prices Review Board - Annual Report 2015
Statistics on "Cancer"
- Number of deaths caused by selected chronic diseases worldwide as of 2016 (in 1,000)
- Number of cancer deaths worldwide in 2016, by major type of cancer
- Prevalence of diagnosed cancer conditions in selected countries as of 2018
- Distribution of diagnosed cancer in selected countries as of 2018, by gender
- Lifestyle among patients with cancer in selected countries as of 2018*
- Availability of new cancer drugs launched in 2012-2016 in selected countries as of 2017
- Percentage of global oncology spending in 2010, 2015, and 2017, by region*
- Distribution of the 10 leading causes of death in the United States in 2017
- Percentage of U.S. population who has (or ever had) cancer between 2000 and 2016, by age
- Estimated number of new cancer cases and deaths in the U.S. for 2019, by gender*
- Probability of developing invasive cancer in the U.S. for the period 2013-2015, by gender and age
- Incidence rates for cancer in the United States for the period 2011-2015, by gender (per 100,000 population)
- Incidence rate of cancer in the U.S. for the period 2011-2015, by ethnic group and gender (per 100,000 population)
- Estimated number of new cancer cases among men in the U.S. in 2009 and 2019, by cancer type*
- Estimated number of new cancer cases among women in the U.S. in 2009 and 2019, by cancer type*
- U.S. states with the highest cancer incidence rates in 2014 (per 100,000 population)*
- U.S. states with the lowest cancer incidence rates in 2014 (per 100,000 population)*
- Deaths by cancer in the U.S. from 1950 to 2016 (per 100,000 population)*
- Cancer death rates in the United States for the period 2012-2016, by type and gender (per 100,000 population)
- Cancer death rates in the U.S. for the period 2012-2016, by ethnic group and gender (per 100,000 population)
- Estimated number of cancer deaths among men in the U.S. in 2009 and 2019, by cancer type
- Estimated number of cancer deaths among women in the U.S. in 2009 and 2019, by cancer type
- Deaths by prostate cancer in the U.S. from 1950 to 2016 (per 100,000 population)
- Deaths by breast cancer in the U.S. from 1950 to 2016 (per 100,000 population)
- U.S. states with the highest cancer death rates in 2016 (per 100,000 population)*
- U.S. states with the lowest cancer death rates in 2016 (per 100,000 population)*
- Five-year relative cancer survival rates in the U.S. for the period 2008-2014, by type of cancer
- Five-year relative cancer survival rates in the U.S. in periods between 1975 and 2014, by ethnic group
- Number of U.S. Americans with a history of cancer living between 2004 and 2016 (in millions)
- Percentage of U.S. adults who believed the following increased a person's risk of getting cancer as of 2018
- Percentage of U.S. adults with cancer that had select lifestyle habits as of 2018, by age
- Proportion of cancer deaths attributable to cigarette smoking among adults 30 years and older in the U.S. in 2014, by cancer type
- Rate of overweight and obesity-related invasive cancer cases in the United States in 2014, by cancer type (per 100,000 population)
- Relative risk for select colorectal cancer risk factors in the U.S. as of 2017*
- Percentage of U.S. adults who did the following to reduce their risk of getting cancer as of 2018
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)
- Top 3 therapeutic areas by spending in the U.S. from 2012 to 2016 (in billion U.S. dollars)
- Top 10 pharmaceutical companies based on global oncology revenue in 2017 and 2024 (in million U.S. dollars)
- Top 5 oncology products worldwide based on revenue in 2017 and 2024 (in million U.S. dollars)*
- Leading U.S. oncology brands based on revenue in 2016 (in million U.S. dollars)
- Number of cancer drugs in development in the United States in select years between 2005 and 2018
- Spending growth on new brand specialty medicines in the United States in 2014 and 2015, by type (in billion U.S. dollars)
- Expenditure on biosimilars in the United States in 2014, by type (in billion U.S. dollars)*
- Expenditure on specialty medicines in the United States from 2012 to 2016, by type (in billion U.S. dollars)
- Expenditure on multiple sclerosis medicines in the United States from 2010 to 2014, by type (in billion U.S. dollars)
- New molecular entities availability worldwide as of 2013, by therapy area
- Share of products in clinical development and review that had potential to be first-in-class in 2016, by therapeutic area
- Forecast of global medicine spending distribution in 2020, by area of disease*
- Top 20 therapy areas in the United States in 2016, by number of prescriptions (in millions)
- Distribution of payment types for prescriptions dispensed in the U.S. from 2012 to 2016
- Time from NDA/BLA filings for new drugs to FDA approval in select disease areas in the U.S. between 2006 and 2015
- Citalopram out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*
- Likelihood of approval from Phase I for new drugs in select disease areas in the U.S. between 2006 and 2015
- Top 10 pharmaceutical therapeutic classes worldwide in 2010 by sales (in billion U.S. dollars)
- Percent approval for NDA/BLA filings for new drugs in select disease areas in the U.S. between 2006 and 2015
- Per capita prescription drug expenditure for under 26-year-olds in the U.S. between 2010 and 2020, by insurance status (in U.S. dollars)
- Domestic sales value of medical chemical products in Taiwan between 2008 and 2017 (in billion New Taiwan dollars)
- Share of individuals taking prescribed medicine for a year or more in Northern Ireland in 2013, by age
- Consumption of antibacterials for systemic use in Netherlands in 2016 (in DDD per 1,000 inhabitants per day)
- Labor productivity index (LPI) of medicine products in Japan from 2008 to 2017
- Total expenditure on prescription drugs in the U.S. in 2010, 2015 and 2020 (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account |
Instant Access
Premium Account | ||
|---|---|---|---|
Our servicesClick the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.